🇺🇸 NBIX — Neurocrine Biosciences, Inc.

Salud Compra fuerte
← Volver

Precio actual

164,63 USD

Máx. histórico

185,50

99 días

Caída desde máximo

-11,25%

Rango 52 semanas

122,14 – 186,12

Variación hoy

+3,05%

Cierre anterior

159,76

Rango de hoy

158,66 – 165,86

Volumen hoy

1.507.456

Peor caída histórica

-97,21%

15/03/2006 → 12/11/2009

Recuperado en 2911 días

Volatilidad anualizada ⓘ

61,30%

Información
Nombre completo
Neurocrine Biosciences, Inc.
Divisa
USD
Mercado
NasdaqGS
Sector
Salud
Industria
Drug Manufacturers - Specialty & Generic
Empleados
2.500
PER ⓘ
24,43 (puede no estar actualizado)
Dividend yield
0,00% (puede no estar actualizado)
Precio objetivo analistas
207,50 USD (puede no estar actualizado)
Primera cotización
23/05/1996
Precio actualizado
hace 1 día
Sobre la empresa

Neurocrine Biosciences, Inc. discovers, develops, and commercialize pharmaceuticals for neurological, psychiatric, endocrine, and immunological disorders in the United States and internationally. The company's products include INGREZZA for tardive dyskinesia and chorea associated with Huntington's disease; Orilissa tablets for endometriosis; Oriahnn capsules to treat uterine fibroids; and CRENESSITY to treat congenital adrenal hyperplasia, as well as offers products under the name of ALKINDI and Efmody. Its product candidates in clinical development includes NBI-1076986 to treat movement disorders; Osavampator for inadequate response to treatment in major depressive disorder; NBI-1117568 for the treatment of schizophrenia and bipolar mania; NBI-1117567 for the treatment of Alzheimer's disease; NBI 921355 for the treatment of epilepsy; NBIP-01435 for the treatment of congenital adrenal hyperplasia; NBIP-2118 for the treatment of obesity and related metabolic diseases; and NBI-1070770 to treat major depressive disorder; and NBI-1117570, NBI-1117567, NBI-1117569, NBI-1140675, and NBI-1065890 for neuropsychiatric and neurological conditions. The company also has license and collaboration agreements with Nxera Pharma UK Limited; Takeda Pharmaceutical Company Limited; Xenon Pharmaceuticals Inc.; Voyager Therapeutics, Inc.; Sanofi S.A.; Tanabe Pharma Corporation; and AbbVie Inc. The company was incorporated in 1992 and is headquartered in San Diego, California.

Rentabilidad mensual
Evolución
Histórico día a día
Fecha Apertura Máximo Mínimo Cierre Variación Volatilidad día Volumen
15/01/2015 31,15 32,08 30,22 30,60 -1,23% 5,97% 1.726.800
14/01/2015 29,54 31,12 29,29 30,98 +2,79% 6,19% 1.032.400
13/01/2015 29,90 30,80 29,36 30,14 +2,13% 4,82% 2.066.900
12/01/2015 28,37 29,64 27,08 29,51 +4,31% 9,02% 1.743.500
09/01/2015 27,21 29,25 27,13 28,29 +2,95% 7,79% 2.781.900
08/01/2015 27,11 29,21 25,56 27,48 +25,59% 13,46% 8.538.700
07/01/2015 20,78 22,07 20,70 21,88 +6,58% 6,59% 931.400
06/01/2015 21,75 22,06 19,68 20,53 -4,07% 10,94% 1.639.700
05/01/2015 22,87 23,10 21,10 21,40 -6,30% 8,75% 1.200.800
02/01/2015 22,59 23,19 22,35 22,84 +2,24% 3,72% 665.800
31/12/2014 22,27 22,85 21,90 22,34 +0,40% 4,27% 1.015.300
30/12/2014 22,38 22,54 22,13 22,25 -0,67% 1,83% 331.800
29/12/2014 22,65 23,28 22,14 22,40 -1,62% 5,03% 633.900
26/12/2014 21,54 22,79 21,43 22,77 +6,75% 6,31% 389.700
24/12/2014 21,33 21,69 20,91 21,33 +0,42% 3,66% 434.500
23/12/2014 23,26 23,81 21,17 21,24 -8,33% 11,35% 907.400
22/12/2014 24,51 24,53 23,01 23,17 -5,39% 6,20% 975.200
19/12/2014 23,76 24,86 23,22 24,49 +2,47% 6,90% 2.188.400
18/12/2014 23,02 23,98 22,54 23,90 +6,03% 6,26% 1.060.300
17/12/2014 20,45 22,56 20,19 22,54 +10,17% 11,59% 1.056.500
16/12/2014 20,99 21,25 20,39 20,46 -0,87% 4,10% 711.800
15/12/2014 22,12 22,12 20,56 20,64 -6,05% 7,05% 946.200
12/12/2014 21,45 22,50 21,45 21,97 +0,55% 4,90% 1.187.100
11/12/2014 22,00 22,49 21,83 21,85 -0,18% 3,00% 1.247.600
10/12/2014 19,74 22,00 19,73 21,89 +10,50% 11,50% 2.009.000
09/12/2014 18,72 19,84 18,59 19,81 +4,43% 6,68% 713.200
08/12/2014 19,31 19,90 18,89 18,97 -1,40% 5,23% 1.058.700
05/12/2014 19,25 19,43 18,77 19,24 +0,00% 3,43% 686.700
04/12/2014 19,28 19,62 19,20 19,24 -0,72% 2,18% 283.400
03/12/2014 19,90 19,90 19,09 19,38 -2,61% 4,07% 622.300